1-11 of 11
von willebrand disease
Close
Sort by
Journal Articles

Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Luciano Baronciani, Ian Peake, Reinhard Schneppenheim, Anne Goodeve, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Olga Benitez, Imre Bodó, Ulrich Budde, Andrea Cairo, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Wolf Hassenpflug, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W. G. Leebeek, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Renato Marino, Nikolas Nikšić, Florian Oyen, Cristina Santoro, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Eva M. K. Zetterberg, Jeroen Eikenboom, Augusto B. Federici, Flora Peyvandi
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2987–3001.
https://doi.org/10.1182/bloodadvances.2020003397
Published: 2021
Includes: Supplemental data
Journal Articles

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

Laura H. Bukkems, Jessica M. Heijdra, Nico C. B. de Jager, Hendrika C. A. M. Hazendonk, Karin Fijnvandraat, Karina Meijer, Jeroen C. J. Eikenboom, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Marjon H. Cnossen, Ron A. A. Mathôt
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1513–1522.
https://doi.org/10.1182/bloodadvances.2020003891
Published: 2021
Includes: Supplemental data
Journal Articles

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

Nathan T. Connell, Veronica H. Flood, Romina Brignardello-Petersen, Rezan Abdul-Kadir, Alice Arapshian, Susie Couper, Jean M. Grow, Peter Kouides, Michael Laffan, Michelle Lavin, Frank W. G. Leebeek, Sarah H. O’Brien, Margareth C. Ozelo, Alberto Tosetto, Angela C. Weyand, Paula D. James, Mohamad A. Kalot, Nedaa Husainat, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2021) 5 (1): 301–325.
https://doi.org/10.1182/bloodadvances.2020003264
Published: 2021
Includes: Supplemental data
Journal Articles

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Paula D. James, Nathan T. Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra Haberichter, Vicki Jacobs-Pratt, Barbara Konkle, Claire McLintock, Simon McRae, Robert R. Montgomery, James S. O’Donnell, Nikole Scappe, Robert Sidonio, Jr, Veronica H. Flood, Nedaa Husainat, Mohamad A. Kalot, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2021) 5 (1): 280–300.
https://doi.org/10.1182/bloodadvances.2020003265
Published: 2021
Includes: Supplemental data
Journal Articles

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Hannah K. Lohmeier, Tricia L. Slobodianuk, Sachiko Kanaji, Sandra L. Haberichter, Robert R. Montgomery, Veronica H. Flood
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4065–4068.
https://doi.org/10.1182/bloodadvances.2020002629
Published: 2020
Journal Articles

Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease

Clinical Trials & Observations
Nicoletta Machin, Margaret V. Ragni
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3234–3238.
https://doi.org/10.1182/bloodadvances.2020002046
Published: 2020
Journal Articles

Low VWF: insights into pathogenesis, diagnosis, and clinical management

James S. O’Donnell
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3191–3199.
https://doi.org/10.1182/bloodadvances.2020002038
Published: 2020
Journal Articles

Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms

Ashley Cartwright, Simon J. Webster, Annika de Jong, Richard J. Dirven, Lisa D. S. Bloomer, Ahlam M. AL-Buhairan, Ulrich Budde, Christer Halldén, David Habart, Jenny Goudemand, Ian R. Peake, Jeroen C. J. Eikenboom, Anne C. Goodeve, Daniel J. Hampshire
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2979–2990.
https://doi.org/10.1182/bloodadvances.2018027813
Published: 2020
Includes: Supplemental data
Journal Articles

New therapies for von Willebrand disease

Pier Mannuccio Mannucci
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3481–3487.
https://doi.org/10.1182/bloodadvances.2019000368
Published: 2019
Journal Articles

Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets

Caterina Casari, David S. Paul, Sophie Susen, Cécile Lavenu-Bombled, Annie Harroche, Raymond Piatt, Kathryn O. Poe, Robert H. Lee, Marijke Bryckaert, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis, Wolfgang Bergmeier
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1417–1428.
https://doi.org/10.1182/bloodadvances.2017014290
Published: 2018
Includes: Supplemental data
Journal Articles

Blood volume–based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease

Clinical Trials & Observations
Margaret V. Ragni
Journal: Blood Advances
Blood Adv (2017) 1 (11): 703–706.
https://doi.org/10.1182/bloodadvances.2017005090
Published: 2017